Online Abortion Drug Sales in Indonesia: A Quality of Care Assessment.

IF 1.9 3区医学 Q2 DEMOGRAPHY

Studies in Family Planning Pub Date : 2020-12-01 Epub Date: 2020-10-20 DOI:10.1111/sifp.12138

Ann M Moore, Jesse Philbin, Iwan Ariawan, Meiwita Budiharsana, Rachel Murro, Riznawaty Imma Aryanty, Akinrinola Bankole

{"title":"Online Abortion Drug Sales in Indonesia: A Quality of Care Assessment.","authors":"Ann M Moore, Jesse Philbin, Iwan Ariawan, Meiwita Budiharsana, Rachel Murro, Riznawaty Imma Aryanty, Akinrinola Bankole","doi":"10.1111/sifp.12138","DOIUrl":null,"url":null,"abstract":"<p><p>This study sought to understand the experience of buying misoprostol online for pregnancy termination in Indonesia. We conducted a mystery client study August through October, 2019. Interactions were analyzed quantitatively and qualitatively, along with the contents of the packages. One hundred ten sellers were contacted, from whom mystery clients made 76 purchases and received 64 drug packages. Almost all sellers sold \"packets\" containing multiple drugs; 73 percent of packets contained misoprostol, and 47 percent contained at least 800 mcg of misoprostol. Thirty-four packets contained insufficient drugs to complete an abortion. When compared to WHO standards, 87 percent of sellers imparted incomplete information about potential physical effects; no seller provided information about possible complications. Women buying misoprostol from informal online drugs sellers will be underprepared for understanding potential side effects and complications. Educational activities are needed to increase women's access to information about safe use of misoprostol as a harm reduction strategy.</p>","PeriodicalId":22069,"journal":{"name":"Studies in Family Planning","volume":"51 4","pages":"295-308"},"PeriodicalIF":1.9000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/sifp.12138","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Studies in Family Planning","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/sifp.12138","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/10/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"DEMOGRAPHY","Score":null,"Total":0}

引用次数: 6

Abstract

This study sought to understand the experience of buying misoprostol online for pregnancy termination in Indonesia. We conducted a mystery client study August through October, 2019. Interactions were analyzed quantitatively and qualitatively, along with the contents of the packages. One hundred ten sellers were contacted, from whom mystery clients made 76 purchases and received 64 drug packages. Almost all sellers sold "packets" containing multiple drugs; 73 percent of packets contained misoprostol, and 47 percent contained at least 800 mcg of misoprostol. Thirty-four packets contained insufficient drugs to complete an abortion. When compared to WHO standards, 87 percent of sellers imparted incomplete information about potential physical effects; no seller provided information about possible complications. Women buying misoprostol from informal online drugs sellers will be underprepared for understanding potential side effects and complications. Educational activities are needed to increase women's access to information about safe use of misoprostol as a harm reduction strategy.

Abstract Image

查看原文本刊更多论文

在线堕胎药物销售在印度尼西亚:护理质量评估。

本研究旨在了解印度尼西亚在线购买米索前列醇用于终止妊娠的经验。我们在2019年8月至10月进行了一项神秘客户研究。与包的内容一起，定量和定性地分析了相互作用。他们联系了110个卖家，神秘客户从这些卖家那里购买了76个药品，收到了64个药品包装。几乎所有的卖家都出售含有多种药物的“包装”;73%的包装含有米索前列醇，47%的包装含有至少800微克的米索前列醇。34包药物不足以完成流产。与世界卫生组织的标准相比，87%的销售商对潜在的身体影响提供了不完整的信息;没有卖家提供可能出现并发症的信息。从非正式的网上药品销售商那里购买米索前列醇的妇女对了解潜在的副作用和并发症准备不足。需要开展教育活动，以增加妇女获得关于安全使用米索前列醇的信息，作为一项减少危害的战略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Studies in Family Planning Multiple-

CiteScore

4.00

自引率

9.50%

发文量

期刊介绍： Studies in Family Planning publishes public health, social science, and biomedical research concerning sexual and reproductive health, fertility, and family planning, with a primary focus on developing countries. Each issue contains original research articles, reports, a commentary, book reviews, and a data section with findings for individual countries from the Demographic and Health Surveys.